1 January 2018 in Turkish Journal of Hematology
1 November 2021 in Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
Introduction: Ductal carcinoma in situ is a non-invasive pathology of breast cancer. Pure ductal carcinoma in situ is extremely rare, although it is often accompanied by invasive breast cancers. Materials and Methods:The study included 27 patients who applied to the Adana City Training and Research Hospital Radiation Oncology outpatient clinic and received adjuvant radiotherapy with a diagnosis of pure ductal carcinoma in situ. Results:The mean age of the patients was 45.33 in the premenopausal period and 59.83 in the postmenopausal period, and a statistically significant result was obtained when the age of both groups was compared (p = 0.001). Age and tumor diameter (38.8%) was assessed statistically significant (p <0.05). it can be stated that the tumor diameter tends to increase with increasing age. Conclusion: Age, tumor size, receptor status, operation margin, histopathological grade, multifocality and adjuvant treatments are effective on local recurrens and survival in ductal carcinoma in situ patients. Patients diagnosed with ductal carcinoma in situ receive adjuvant radiotheray after breast conserving surgery, reducing the risk of local recurrens.
15 July 2022 in Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
Amaç: Bu çalışmada, prostat kanserlerinde metastatik kemiğe radyoterapi uygulanan hastalarda sağ kalım üzerine etkili olabileceği düşünülen faktörlerin karşılaştırılması amaçlanmıştır. Gereç ve Yöntemler: Prostat kanserinin kemik metastazı nedeniyle radyoterapi almış olan 92 hasta çalışmaya dahil edilmiştir. Bulgular: Yetmiş yaşından küçük hastalarda %57.1 oranında ölüm gözlenirken, >70 yaş hastalarda bu oran %74 olarak belirlenmiştir. Bu değerlerin karşılaştırılmasında her ne kadar istatistiksel olarak anlamlı fark görülmese de >70 olan hastaların ≤70 hastalara göre ölüm riskinin 2.135 kat daha yüksek olma eğiliminde olduğu gözlenmiştir (p>0.05). Visseral organ metastazı ile birlikte kemik metastazı olan hastalarla, yalnız kemik metastazı olan hastaların sağ kalımı karşılaştırıldığında istatistiksel olarak anlamlı sonuç bulunmuştur (p
30 September 2025 in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
Aim: Lung cancer (LC) is the most common among malignant tumors. Cure is not possible in patients with stage-4. These patients receive palliative radiotherapy (RT), chemotherapy and supportive care. This study aims to examine the relationship between survival time and some biochemical features in stage-4 patients who received palliative RT to their lungs. Methods: 51 patients who applied to our hospital for palliative RT to their lungs between July 2016 and May 2022 were included in the study. All patients; age, survival rate, gender and type of carcinoma [non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC)]; alanine aminotransferase, aspartate amino transferase, sodium, potassium, hematocrit, hemoglobin, lymphocyte, neutrophil, platelet, urea and lactate dehydrogenase values were measured. Correlation coefficients along with descriptive statistics were computed for these features. Resuls: All patients have stage-4 LC. 13 (25.49%) patients are female and 38 (74.50%) patients are male. NSCLC had 41(80.39%) of all patients, SCLC pathology had 10 (19.60%) of all patients.All patients received palliative RT to their lungs. While the median survival time for patients diagnosed with NSCLC was 18 weeks, the median survival time for patients with SCLC pathology was found 4 weeks. Conclusion:The overall survival time for both groups was found 16 weeks. Relationships between survival time and some biochemical properties were determined in patients with stage-4 LC who received palliative RT to the lungs. Survival time in NSCLC group patients was found to be approximately 4 times higher than in SCLC group patients.
21 March 2022 in Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
Objective: The aim of this study is to investigate the effect of adjuvant radiotherapy applied on patients with invasive breast cancer on survival and to determine the relationship between prognostic factors and survival in patients. Introduction: Breast cancer is the most common cause of death in women between the ages of 35-55. Surgery, chemoradiotherapy, radiotherapy, hormone therapy and immunotherapy are treatment modalities applied in breast cancers. Materials and Methods: Our retrospective study included 120 patients ranging between 39 and 68 years who were admitted to Adana City Education and Research Hospital Radiation Oncology outpatient clinic between May 2016 and March 2019 and who received adjuvant radiotherapy due to invasive breast cancer. Results: Statistically significant findings were obtained between lymphovasculer invasion, human epidermal growth factor receptor 2 positivity, tumor and lymph node status and overall survival. But, no statistically significant findings could be attained between menapause status, surgical method applied, histopathological type of tumor, presence of extracapsular invasion, estrogen and progesterone hormone receptors and overall survival. Discussion: Statistically insignificant results are thought to arise from insufficient number of patients incorporated in the study, however, their effect on overall survival was exhibited. Although early diagnosis with modern imaging methods increases overall survival in breast cancer, the selection of appropriate treatments for suitable patients is crucial. Conclusion: Even though we could not specify enough statistically, we concluded that adjuvant radiotherapy positively affected survival in the light of previous studies in the literature and our observations during present study.